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Abstract. We investigated _27 azulene delivatives for their 
relative cytotoxicity against three human normal cells and three 
human oral tumor cell lines. 2-Acetylaminoazulene f4], diethyl 
2-chloroazulene-1, 3-dica,horylate f9J a,rd methyl 7-isopl'opyl-2-
methoryazulene-l-carboxylate [24J showed highe,' tumor-
speclfic cytotoxicity than azulene flJ and guaiazulene f2J. Four 
1- and 3-halogenated compounds showed lower tumor 
speclficity. The tumol'-speclfic cytotoxic activity seems not to be 
related to the position offun,ctional groups. All compounds 
showed no anti-HIV activity. Methyl 7-isop,'opyl-2-
methoryazulene-1-carboxylate f24J induced apoptotic cell death 
(characterized by internucleosomal DNA fi'agmentation and 
caspase 3 activation) in HL-60 cells. ESR spectroscopy showed 
that methyl 7-isopivpyl-2-methoxyazulen,e-1-ca/'boxylate f24J 
did not produce radical and less efficiently scavenged 02-
(gene,'ated by HX-XOD reaction) and NO (generated fl'oln 
NOC-7). These data suggest that a radical-mediated oxidation 
mechanism may not be involved in the apoptosis induction by 
methyl 7-isopropyl-2-lnethoryazulene-l-ca!boxylate f24J. 
Azulene [1] (structure shown in Figure I ) is an isomer to 
naphthalene, has a dipole moment and a resonance energy 
intermediate between that of benzene and naphthalene, but 
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is considerably more reactive (1-4). Azulene derivatives have 
shown sever bio ogical activities, including antibacterial 
activity (5), anti-ulcer activity (6), relaxant activity (7), 
inhibition of thr mboxane A.-induced vasoconstriction and 
thrombosis (8), acute toxicity and local anesthetic activity (9). 
The ccumulation of guaiazulene [2] at the mucous 
membrane suggested i s application for chemotherapy of 
mucous membrane di eases (10, 11). However, the effects of 
azulene derivatives on cellular function have not been 
inves igated in detail. We investigated here whether a total of 
27 azulene derivatives displ y tumor-specific cytotoxic a.ctivity, 
using three normal human cells [gingival fibroblast (HGF), 
pulp cell (HPC), periodontal ligament fibroblast (HPLF)] and 
thre  human oral tumor cell lines [submandibular gland 
carcinoma (HSG) and oral squamous cell carcinoma (HSC2, 
HSC-3)] and, if so, whether they induce apoptosis-associatecl 
characterist cs (such as DNA fragmentation a~nd caspase 
activ tion) n hurnan tumor cells. We also investigated 
wh ther a radical-mediated mechanism is involved in th,e 
azulene-induced cyiotoxicity, using ESR spectroscopy. 
Materials and M thods 
Methods. The following chemicals and reagents were obtained from 
the indicated companies: Azulene [1], guaiazulene [2] (Tokyo 
Kasei Kogyo Co., Ltd., Tokyo, Japan); Dulbeccos's modified F.agle 
medium (DMEM), RPMI 1640 (Gibco BRL, Grand Island, NY, 
USA); fetal bovine serum (FBS)(JRH, Bioscience, Lenexa, T:*(S, 
USA); dimethyl sulfoxide (DMSO), diethylenetriarninepel,7taacet~ie 
acid (DETAPAC) (Wako Pure Chem, Ind, Ltd, Osaka, Japan~; 3 
(4,5-dimethyl hiazol-2-yl)-2,2-diphenyltetrazolim~~ bra~.~lide (i'*/f'~TT'), 
hypoxanthine (HX), xanthi~~.e oxid:.~se (XOD), S'~~;id~.','~'+' :'*"-
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Figure I . Structure of azulene derivatives. 
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dideoxythymidine (AZT), dideoxycyiidine (ddC) (Sigma Chem Co., 
St. Louis. MO, USA); 5,5-dimethyl-1-pyrroline-N-oxide (DMPO), 
superoxide dismutase (SOD) from bovine erythrocytes, 1-hydroxyl-
2-0x0-3-N-3-methyl-3-aminopropyl)-3-methyl-l-triazene (NOC-7) 
and 2- (4-carboxyphenyl) -4,4,5 ,5 -tetramethylimidazoline- I -oxyl-3-
oxide (carboxy-PTIO) (Dojin, Kumamoto, Japan). 
Synthesis of azulene derivatives. Azulene derivatives were 
synthesized, according to the published reports: Azulene [1] (12-
14), guaiazulene [2] (12-14), 2-aminoazulene [3] (15-17), 2-
acetylaminoazulene [4] (15-17), 2-methoxyazulene [5] (18, 19), 2-
chloroazulene [6] (20), diethyl 2-aminoazulene-1,3-dicarboxylate 
[7] (15, 17, 19, 21), 2-amin0-1,3-dicyanoazulene [8] (15, 17, 19, 
21), diethyl 2-chloroazulene-1,3-dicarboxylate [9] (20), diethyl 
azulene-1,3-dicarboxylate [10] (17), 1,3-difluoroazulene [1l] (22), 
1,3-dichloroazulene [12] (23, 24), 1,3-dibromoazulene [13] (25), 
1,3,5-tribromoazulene [14] (24, 26), 1-methylazulene [15j (27-30), 
methyl azulene-1-carboxylate [16] (28, 29), methyl 3-
methylazulene-1-carboxylate [17] (28, 29), methyl 2-
methylazulene-1-carboxylate [18] (28, 29), dimethyl 2-amin0-5-
isopropylazulene 1,3-dicarboxylate [19] (15, 17, 19, 21), dimethyl 
5-isop opyl-2-hydroxyazulene-1,3-dicarboxylate [20] (15, 17, 19, 
21), methyl 3 ethyl-7-isopropylazulene-1-carboxylate [2l] (28, 29), 
methyl 3-cyan0-2-hydroxy-7-isopropylazulene-l-carboxylate [22] 
(15, 17, 19, 21), 5-isopropyl-2-methoxyazulene [23] (18, 19), methyl 
7-isopropyl-2-methoxyazulene-l-carboxylate [24] (18, 19), methyl 
2H-cyclohepta[b]furan-2-0ne-3-carboxylate [25] (31), ethyl 8-
hydroxy-2H-cyclohepta[b]furan-2-0ne-3-carboxylate [26] (32) and 
ethyl 8-ac toxycycloheptaLb]furan-2-0ne-3-carboxylate [27] (32). 
Cell culture. Three human oral tumor cell lines (HSG, HSC-2, HSC-3) 
and three human normal cells LHGF (5-8 population doubling level 
(PDL)), HPC (5-8PDL), HPLF (5-8PDL)] were cultured in DMEM 
supplemented with 10% heat-inactivated FBS. Human promyelocyiic 
leukem c HL-60 c lls were cultured in RPMI 1640 supplemented with 
10% FBS. Normal cells were prepared from periodontal tissues, 
according to the guideline of Meikai University Ethics Committee, 
after obtaining informed consent from the patients. 
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Table I . Cytotoxic activity of azu!enes. 
Cytotoxic activity (CC50: mM) 
Molecular 
Compd. Weight 
Normal human ceils Human tumor cell lines 
HGF HPC HPLF HSG HSC-2 HSC-3 TS 
?
?
?
?
?
?
?
??
10 
11 
12 
13 
14 
15 
16 
17 
18 
1 9 
20 
21 
22 
23 
24 
25 
26 
27 
128.17 
198.31 
143.19 
20 1 . 23 
158.20 
162.62 
287.32 
193.21 
307.76 
272.3 O 
164.16 
197.06 
285.97 
3 64.86 
142.20 
1 86.2O 
200.24 
200.24 
301.34 
3 02.3 3 
256.35 
269.30 
200. 14 
258.32 
204.19 
234.21 
276.25 
2.38 
O.40 
> 2.79 
> I .99 
1 .82 
2.39 
O.98 
> 2.07 
1.22 
1 .41 
O.91 
1.78 
0.27 
O.42 
O._55 
O . 76 
O.41 
O.39 
O.95 
O.95 
O.35 
O.96 
O.48 
O.18 
> I .96 
1 .30 
1 .04 
2.-52 
O.19 
>2.79 
> I .99 
1.61 
>2.46 
O.81 
> 2.02 
> I .3 
> I .47 
1.01 
1.77 
O.26 
0.3 2 
O.59 
O.43 
O.36 
O.38 
O . 85 
O.65 
O.30 
l.12 
0.40 
O.43 
1.80 
l .35 
0.96 
2.29 
0.19 
>2.79 
> 1.99 
1.71 
1.86 
O.92 
>2.07 
> i .3 
1 .43 
O.90 
1 .85 
O.30 
O.43 
O.54 
O.45 
O.40 
O.38 
O.9_~~ 
0.78 
O.30 
O.84 
O.43 
O.17 
> I .96 
1 .2_5 
O.98 
2.50 
O.11 
>2.79 
O.34 
1 .28 
> 2.46 
> I .39 
O.24 
O.18 
1.17 
O.79 
> 2.03 
O.31 
O.41 
O.60 
O . 25 
O.22 
O.22 
1.07 
O.87 
O.16 
O.89 
O.22 
0.1 1 
O.83 
1.29 
1 .O1 
1.33 
O.16 
>2.79 
O.34 
O.61 
O.42 
O.64 
1.47 
O . 24 
1.30 
0.62 
1.06 
O.19 
O.17 
O.58 
O.45 
O.25 
0.14 
O.28 
O.43 
O.18 
O.84 
O.46 
O.11 
1.42 
1 .20 
O.83 
2.33 
0,12 
> 2.79 
O.98 
O.92 
O.65 
1,17 
1.00 
O.25 
> I .47 
O.58 
1 .40 
O.15 
O.30 
O.51 
0,35 
O*49 
O.35 
O,80 
0,38 
O.29 
O.78 
0.23 
O.11 
1.68 
1.26 
O.96 
1 .2 
2.0 
>< 1.0 
>3.6 
l .8 
>< 1.9 
< O.8 
> 2.3 
>5.7 
><1.1 
1.4 
<1.2 
1.3 
1 .3 
1.0 
1 .6 
1 .2 
1.6 
1.3 
1.4 
1.5 
l.2 
1 .4 
2.4 
> I .5 
1.0 
1.1 
Assay for c'ytotoxic activity. Ce]Is (other than HL-60 cells) ¥vere 
inoculated at 12 x 103 cells/well in 96-micro¥vell (Becton Dickinson 
Labware, NJ, USA), unless otherwise stated. After 24 hours, the 
medium was removed by suction with an aspirator and replaced 
with 0.1 mL of fresh medium containing various concentrations of 
test compounds. Ceils were incubated for another 24 hours and 
the relative viable cell number was then determined by MTT 
method. In brief, cells were replaced with fresh culture medium 
containing O.2 mg/mL MTT and incubated for another 4 hours. 
The cells were lysed with O.1 mL of DMSO and the absorbance at 
540 nm of the celi lysate was determined, using a microplate 
reader (Biochromatic Labsystem, Helsinki, Finland) (33). The 
A540 of control cells were usually in the range of O.40 to O.90. The 
500/(; cytotoxic concentration (CC50) ¥vas determined from the 
dose-response curve. Tumor specificity (TS) was determined by 
the following equation. 
[CC50 (HGF)] + [CC50 (HPC)] + [CC_)-(~~ (HPLF)] 
TS = 
[CC_,..o (HSG)] + [CC50 (HSC-2)] + [CC50 (HSC-3)] 
The viability of HL-60 cells was determined by trypan blue 
exclusi n. HL-60 cells were inoculated at 5 x 104/0.1 mL in 96-
microw ll and various concentrations of test compounds were 
added. Afte  incubation for 24 hours, the viable cell nmnber was 
determined a described previously. The cell density of control cells 
a  cell harvest was in the range of 8-9 x 105/mi. 
Assay .for DNA fl'ag,nentation. Cells were lysed ¥vith 50 uL of 
lysate buffer L50 mM Tris-HCI (pH 7.8), 10 mM EDTA, O.5010 
(w/v) sodium N-l ur yl-sarcosinate solution]. The solution was 
incubated ¥v th O.4 mg/mL RNase A and 0.8 mg/mL proteinase K 
for 1-2 hours at 50'C. After incubation, the lysate was mixed 
with 50 uL of Nal solution L7.6 M NaJ, 20 mM EDTA-2Na, 40 
mM Tris-HCl, pH 8.0]. The lysate was mixed with 250 uL of 
ethanol and centrifuged for 20 minutes at 20,000 xg. The 
precipitate ¥vas washed with I mL of 700/0 ethanol and dissolved 
in TE buffer (10 mM Tris-HCl, I mM EDTA, pH 7.5). A sample 
(10-20 uL) ¥vas applied to 2clo agarose *"el electrophoresis in TBE 
buffer (89 mM Tris-HC], 89 mM boric acid, 2 mM EDTA, pH 
8.0). DNA molecular marker (Takara) and DNA from apoptotic 
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HL-60 cells induced by UV were used for calibration (34). The 
DNA fragmentation pattern was examined in photographs taken 
under UV illumination. 
Table II. Ant -HIV activity of azulene. 
Compd. CC50 (mM) EC50 (mM) SI 
Assay for caspase activation. Cells were washed with PBS and 
lysed in lysis solution (MBL, Nagoya, Japan). After standing for 
10 minutes on ice and centrifugation for 5 minutes at 10,000 xg, 
the supernatant was collected. The lysate (50 uL, equivalent to 
200 ug protein) was mixed with 50 uL 2x reaction buffer (MBL) 
containing substrates for caspase 3 (DEVD-pNA (p-
nitroanilide)) , caspase 8 (IETD-pNA) or caspase 9 (LEHD-
pNA ). After incubation for 2 hours at 37'C, the absorbance at 
405 nm of the liberated chromophore pNA was measured by 
plate reader. 
Assay for radical intensity. The radical intensity of the test sample 
was determined at 25 'C in 0.1 M Tris-HCI buffer (pH 7.4), 0.1 M 
NaHC03/Na2C03 buffer (pH 9, 10) or in 0.1 M KOH (pH 12.5), 
using ESR spectroscopy (JEOL JES REIX, X-band, 100 kHZ 
modulation frequency). Instrument settings: center field, 336.0:t:5.0 
mT; microwave power, 8 mW; modulation amplitude, 0.1 mT; gain, 
630; time constant, 0.03 seconds; scanning time, 2 minutes. The 
radical intensity was defined as the ratio of peak height of these 
radicals to that of MnO (35). 
To determine 02-, produced by HX-XOD reaction (total 
volume: 200 uL) [2 mM HX in 0.1 M phosphate buffer (pH 7.4) 
(PB) 50 uL, 0.5 mM DETAPAC 20 uL, 8% DMPO 30 uL, sample 
(in DMSO) 40 uL, H20 or SOD 30 uL, XOD (0.5 U/mL in PB) 30 
uL], the gain, time constant and scanning time were changed to 
500, 0.1 seconds and I minute, respectively. The radical intensity 
was determined I minute after mixing. The 02- scavenging activity 
was expressed as SOD unit/mg sample, by calibration with the 
standard curve of SOD (35). The concentration required to reduce 
the radical intensity of DMP0-00H by 50% (IC50) was 
determined from the dose-response curve. 
For the determination of NO radical, the sample was added 
to the reaction mixture of 20 uM carboxy-PTIO and 50 uM 
NOC-7 in 0.06 M phosphate buffer, pH 7.4. The gain and 
scanning time were changed to 250 and 2 minutes, respectively. 
The NO radical intensity was defined as the ratio of peak height 
of the Ist peak of carboxy-PTI, which was produced by the 
reaction of NO (derived from NOC-7) and carboxy-PTIO to that 
of MnO (35). 
Assay for anti-human immunodeficiency virus (HIV) activity. MT-4 
cells were infected with HIV-ImB at a multiplicity of infection 
(m,o.i.) of 0.01. HIV- or mock- infected (control) MT-4 cells (1.5 x 
105/mL, 200 uL/well) were placed into 96-well microtiter plates and 
incubated in the presence of various concentrations of test samples. 
After incubation for 5 days at 37'C in a 5% C02 incubator, cell 
viability was quantified by a colorimetric assay (at 540 nm and 690 
nm), monitoring the ability of viable cells to reduce MTT to a blue 
formazan product. The CC50 and 50% effective concentration 
(EC50) were determined from the dose-response curve with mock-
infected or HIV-infected cells, respectively (36). All data represent 
the mean values of triplicate measurements. The anti-HIV activity 
was evaluated by selectivity index (SI), which was calculated by the 
following equation: 
SI=CC50/EC50 
?
?
?
?
?
?
?
?
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
AZ  
ddC 
0,68 
1,10 
0.64 
0,33 
O,39 
0,52 
0,18 
0,067 
0,15 
0.5 
O,71 
0,35 
O,091 
O.30 
1,3 
O,18
0,14 
0,11 
0,067 
0,08 
O,056 
0,092 
0,092 
0.066 
0,30 
0,80 
O.45 
0,0657 
4,859 
> 1.56 
> 0.20 
> 0.14 
> 0.99 
> 1.26 
> 1.23 
> 0.70 
= O.21 
> 0.65 
> 0.73 
> 1.22 
> 1.01 
> 0.14 
> 0.55 
> 1.41 
> 0.21 
> O.20 
> 0.20 
> 0.13 
> 0.13 
> 0.16 
> 0.15 
> 0.20 
> 0.15 
> 0.98 
> O.85 
> 0.72 
0.000012 
0.00243 
<1 
<1 
=5 
<1 
<1 
<1 
<1 
<1 
<1 
<1 
<1 
<1 
<1 
<1 
<1 
<1 
<1 
<1 
<1 
<1 
<1 
<1 
<1 
<1 
<1 
<1 
<1 
5617 
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Results 
Structure and activity relationship. We first investigated 27 
azulene derivatives for their relative cytotoxicity against three 
human normal cells (HGF, HPC, HPLF) and three human 
oral tumor cell lines (HSG. HSC-2, HSC-3) (Table I). 
Azulene [1] showed the lowest cytotoxicity against both 
human tumor cells [CC 0 (HSG)=2.50 mM; CC50 (HSC-
2)=1.33 M; CC50 (HSC-3)=2.33 mM] and normal human 
cells [CC50 (HGF)=2.38 mM; CC50 (HPC)=2.52 mM; CC50 
(HPLF)=2.29 mM], yielding very weak tumor specificity 
(TS = I .2) . 
Guaiazulene [2] showed higher cytotoxicity against 
tumor cells [CC50 (HSG)=0.11 mM; CC50 (HSC-2)=0.16 
mM; CC50 (HSC-3)=0.12 mM] and slightly lower 
cytotoxicity against normal cells [CC50 (HGF)=0.40 mM; 
CC50 (HPC)=0.19 mM; CC50 (HPLF)=0.19 mM], 
yielding a moderate magnitude of tumor specificity 
(TS = 2. O) . 2-Acetylaminoazulene [4] , diethyl 2-
chloroazulene-1,3-dicarboxylate [9] and methyl 7-
4750 
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isol"opyl-2-metho~~'azuiene-i-carhoxyla/e [24] in 111.-60 cel!s 
IIL-60 ce!Is were inoculafed a, 5 x 10j ce!lsfl ml_ i,7 2~~weH 
p!a!e, in fresh culllfre medium rRFM11640 + IO% FBS, with 
the indica!cd concentrations of ,1lethy! 7-isrJp,ol'yl-2-
m,,tho~:}'azule,re-1-ca,t,axy!ate [24]. After incubation for 6 
hou,:s. DNA was e,ri,c~cted and apPlied t(, aga,vse ge/ 
elect,opharesis. UV. DNA frow apoptotic IIL-60 ceili induced 
by UV inladiation 
?
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1-carboxylate 
l Actinomyein D 
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Figure 3 At!iwation of caspase 3 by methy! 7-isrJy,ropyl-2-methoxyazulene-1-ca,hoxylate !24] in HL-60 cells. HI.-60 ce!Is we,1~ incubated for 4 haurs 
}t'ithout (c(,ntrrJlj or with 155 !SM ntethy! 7-isopropy!-2-metho,:yazu!ene-1-carb(,xyiate f24] or I /tg!mL actinomyci~ D rpositiv~ control, 
isopropyl-2-methoxyazulene-1-carboxylate [24] showed 
comparable cytotoxic activity against tumor cells, but 
showed much lower cytotoxicity against normal cel]s, 
yielding the highest tumor-specific cytotoxlcity (TS= 
>3 6, >5 7 and 2 4, respectively) 
1,3-Dibromoazulene [13], 1-methylazulene [15], methyl 3-
methylazulene-1-carboxylate [17] , methyl 2-methylazulene-
1-carb ] [18], methyl 3-ethyl-7-isopropylazulene-1-
c rboxylate [2l] and 5-isopropyl-2-methoxyazu]ene [23] 
were highly cytotoxic to both tumor and normal cells, 
yielding little or no tumor specificity (TS=1 3, IJD, 1 2, 1 6, 
1 5 and 1 4, respectlvely) 
1- and 3-Halog nated compounds, such as 1,3-
difluoroazulene [1l], 1,3-dichloroazulene [12], 1,3-
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Figtire 4' ESR 'sl)ectra of b'y 2=acetyla'ninoazl'iiene f4J' cliethyl 2-ch!oivazuiene-1; 3-dicarboxy!ate f9J or met/?yl 7-isol);'ol)yl-2-lnethoryazulene-J-ca'hoxyiate 
f24J (1 tnglml') at inc'easlngpH 
dibromoazulene 113] and 1,3,5-tribromoazulene 114j 
showed lower tumor specificity (TS=1.4, <1~.2, 1.3 and 1.3, 
resp ectively) . 
The tumor-specific cytotoxic activity seems not to be 
r,elated to the position of functional groups, based on the 
following evidence: Although the aminoazulenes ~2-
acetylaminoazulene [4] and 2-amin0-1,3-dicyanoazulene 
[8]) had relatively higher tumor specificity (TS= >3.6 and 
>2.3, respectively), the parent compound (2-aminoazulene 
[3i) and its diester derivatives (diethyl 2-aminoazulene-1,3-
dicarboxylate L7], dimethyl 2-amin0-5-isopropylazulene-1,3-
dicarboxylate [191) showed much less tumor specificity 
(TS= ><1..O, <0.8 and 1.3, respectively). Two 2-
methoxyazulene derivatives (5isopropyl-2-methoxyazulene 
123L methyl 7-isopropyl-2-methoxv.azulene-l-carboxylate 
t24]) showed considerably different tumor specificity to 
each other (TS=1.4 and 2.4, resp6ctively). Two 2-
chloroazulene derivatives, 2chloroazulene [6] and diethyl 
2-chloro azulene- I , 3 - dicarb oxyl ate [ 9 1 , also showed 
considerably different tumor specificity to each other 
(TS= > < 1.9 and >5.7, respectively). 
Most of the compounds, except for compound L3] (SI=5), 
showed no anti-HIV activity (SI<1), whereas two positive 
controls, such as AZT and ddC, showed potent anti-HIV 
activity (SI=5617 and 2002, respectively) (Table II). 
Apoptosis induction. Since methyl 7-isopropyl-2-
methoxyazulene-l-carboxylate [24j showed higher cytotoxicity 
( CC50 = 1_ 4 1 uM) against HL-60 cel Is than 2-
acetylaminoazulene L4] (CC50=720 uM) and diethyl 2-
chloroazulene-1,3dicarboxylate L9] (CC50=395 uM) (data 
not shown), we investigated whether methyl 7-isopropyl-2= 
methoxyazulene-1-carboxylate [241 induced internucleosomal 
DNA f agmentation, a biochemical halhnark, in HL-60 cells. 
Figure 2 shows that this is the case. The optimal concentration 
was 0.155 mM. Methyl 7-isopropyl-2-methoxyazulene-l-
c rboxylate [24] ac ivated caspase 3 to a comparable extent 
as th t attained y actinolrrycin D, without affecting caspase 8 
and 9 activ ty (Figure 3). The apoptosis-inducing activity of 2-
acetylaminoazulene [41 a d diethyl 2-chloroazulene-1,3-
dicarboxylate [9] will be reported elsewhere. 
Radical gene/'ation. 2-Acetylaminoazulene L4j produced 
radical under alk lin  condition (pH 9.0-12.5), whereas diethyl 
2-ch oroazulene-1,3-d carboxylate t9] and methyl 7-isopropyl-
2-m thoxyazul ne-1-carb xylate L241 did not (Figure 4). 
2-Acetylaminoazulene [41 efficiently scavenged 02-
(generated by HX-XOD reaction) (IC50=0.014 mM) 
(Figure 5). On the other hand> the 02- scavenging activity 
of methyl 7-isopropyl-2methoxyazulene-l-carboxylate L241 
was very weak (IC50= 1.61 mM). Diethyl '_-chloroazulene-
1,3-dicarboxylate L91 did not show 02~ scavenging activity 
(IC50>2.6 mM) (Figure 5). 
2-Acetylaminoazulene L4j efficiently scavenged NO 
radical (ge erated from NOC-7) (IC50=0.13 mM), whereas 
diethyl 2-chloroazulene-1,3-dicarboxylate 19i and methyl 7-
isopropyl-2-methoxy zulene-l-carboxylate 124] were inactive 
(IC50= >4.65 and >3.90 mM, respectively) (Figure 6). 
Discussion 
We found that, amo g 27 azulene derivatives, 2-
acetylaminoazulene L4] , diethyl 2chloroazulene-1,3-
dicarboxylate [9] and methyl 7-isopropyl-2-methoxyazulene-
1-carboxylate t24] showed higher tumorspecific cytotoxic 
act vity, as compared with azulene Llj and guaiazulene [2j. 
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The present study demonstrated, for the first time, that 
methyl 7-isopropyl-2-methoxyazulene-l-carboxylate 124] 
induced apoptotic cell death characterized by caspase 3 
activation and DNA fragmentation. At present, the 
mechanism by which methyl 7-isopropyl-2-methoxyazulene-
1-carboxylate [24] activated caspase 3 is unclear, since this 
compound did not significantly activate caspase 8 
(mitochondria-independent extrinsic pathway) and caspase 
9 (mitochondria-dependent intrinsic pathway) (37). We 
found, by observation under light microscope (data not 
shown), that a very low percentage of the cells treated with 
this compound produced apoptotic bodies, possibly inducing 
necrotic cell populations. 
Our ESR study demonstrated that 2-acetylaminoazulene 
L4] produced radical and scavenged O_~- and NO more 
efficiently than diethyl 2-chloroazulene-1,3-dicarboxylate [9] 
and methyl 7-isopropyl-2-methoxyazulene-1-carboxylate 
[24], which did not produce radical and poorly scavenged 
these radical species. This suggests that the two different 
activities, that is radical production and scavenging, are 
present in the same molecule. The present study suggests 
that methyl 7-isopropyl-2-methoxyazulene-l-carboxylate 
[24] may induce apoptotic cell death by a mechanism in 
which radical is not involved, whereas 2-acetylaminoazulene 
[4] may induce cell death by a radical-mediated oxidation 
mechanism. In a parallel study with 27 tropolone 
derivatives, we found that 5-aminotropolone, which 
produced a higher amount of radical and more efficiently 
scavenged 02- and NO than azulenes, induced apoptosis at 
a much lower concentration (38). Further studies are 
underway to elucidate the mechanism by which azulenes 
induce apoptosis in tumor cell lines. 
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